FDA clears Watson generic of Wellbutrin XL antidepressant

06/13/2007 | Forbes

Watson Pharmaceuticals says it has won FDA approval for its generic of Wellbutrin XL, the antidepressant made by Biovail and sold by GlaxoSmithKline. Watson said it plans to market its extended-release version immediately.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ